Company: ANTX
Filing Date: 2025-03-25
Form Type: S-8
Source: 0000950170-25-044432
Chunk: 3

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-03-25
Form: S-8
Chunk 3
---
.1*         |     | Consent of Latham & Watkins LLP (included in Exhibit 5.1).                                                                                                                                                                                                                                                                                          |     |                           |     |            |     |         |     |                 |
| 23.2*         |     | Consent of Independent Registered Public Accounting Firm.                                                                                                                                                                                                                                                                                           |     |                           |     |            |     |         |     |                 |
| 24.1*         |     | Power of Attorney (included on the signature page of this Registration Statement).                                                                                                                                                                                                                                                                  |     |                           |     |            |     |         |     |                 |
| 99.1

#         |     | AN2 Therapeutics, Inc. 2022 Equity Incentive Plan.                                                                                                                                                                                                                                                                                                  |     | 10-K                      |     | 001-41331  |     |    10.3 |     | March 29, 2024  |
| 99.2

#         |     | Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the AN2 Therapeutics, Inc. 2022 Equity Incentive Plan.                                                                                                                                                                                                      |     | S-1                       |     | 333-263295 |     |    10.4 |     | March 4, 2022   |
| 99.3

#         |     | Form of Restricted Stock Unit Grant Notice and Award Agreement under the AN2 Therapeutics, Inc. 2022 Equity Incentive Plan.                                                                                                                                                                                                                         |     | 10-K                      |     | 001-41331  |     |    10.5 |     | March 29, 2024  |
| 99.4

#         |     | AN2 Therapeutics, Inc. 2022 Employee Stock Purchase Plan.                                                                                                                                                                                                                                                                                           |     | 10-K                      |     | 001-41331  |     |    10.6 |     | March 29, 2024  |
| 107.1*        |     | Filing Fee Table.                                                                                                                                                                                                                                                                                                                                   |     |                           |     |            |     |         |     |                 |

* Filed herewith.#Indicates management contract or compensatory plan.

### SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8